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Disease/Signs & Symptoms/ 
Nursing Care (select, please see paper for full list) 
Pharyngitis-  
Signs and symptoms include sore throat, fever, swollen lymph nodes, chills, malaise, 
nausea, and vomiting, red and white patches in the throat.  Self-limiting, most signs and 
symptoms subside after 3 to 4 days, but antibiotic treatment should be started within 9 
days after onset of pharyngitis to prevent acute rheumatic fever (ARF) development. 
Nursing Care- Prepare and administer prescribed antibiotics, analgesics.  Educate 
patient/family on the proper use of antibiotics to prevent misuse.  Encourage warm saline 
gargles, and use of throat lozenges, if recommended.  Instruct the patient/family on 
proper mouth care and use of new toothbrush 24 hours after beginning antibiotics.  
Educate patient and family on the benefit of a bland, soft food diet until pain subsides.  
Advise patient/family on increased fluid intake to 2,000 mL/per day where appropriate.  If 
patient cannot swallow, fluids may be administered by I.V. as ordered.  Encourage client 
to wear a disposable mask when exposed to environmental and occupational pollutants.  
Assess and test family for intra-family spread of bacterial infection (Clores, 2015). 
 Impetigo/Pyoderma- 
Signs and symptoms include areas of acne or rash, small patches of inflamed skin, skin 
infections, oozing vesicles, honey colored crust and scales, hair loss, scratching, licking, 
and biting areas of infection, and depression. 
Nursing Care- Teach proper washing and care of vesicles.  Educate patient/family on 
proper use of antibiotics, both oral and topical.  Educate on infection control and 
contagiousness of disease.  Contact precautions should be initiated. Patient linens should 
be washed,kept separate from other family members.  Teach good handwashing. 
Encourage patient to avoid irritants and pollution so additional bacteria and pathogens 
can be avoided until infection subsides.  Keep fingernails cut short (Antipuesto, 2011). 
Invasive GAS infection- 
Sign and symptoms include fever, severe pain, swelling, and redness at wound site. More 
systemic signs such as chills, myalgia, nausea, vomiting, and diarrhea may develop as 
disease/infection progresses.  Changes in blood pressure may occur as disease 
progresses.      
 Nursing Care-Start and maintain I.V. line if indicated.  Monitor temperature.  Administer 
antibiotics as prescribed.  Educate patient/family on proper use of antibiotics.  Wound 
care, educating patient/family on appropriate wound care and infection prevention.  
Prepare and educate patient and family on debridement procedures where indicated.   
Encourage appropriate fluid intake and good nutrition.  Assess and monitor patient for 
signs of sepsis.  Prepare I.V. immunoglobin G therapy if indicated for GAS TSS (Khan, 
2016).  
 Glomerulonephritis 
Signs and symptoms include blood, excess protein in urine, bubbly, foamy urine from 
presence of protein, high blood pressure, peripheral, facial edema, frequent night time 
urination, abdominal pain, and frequent nosebleeds. 
Nursing Care- Provide best rest during acute phase. Monitor and regularly assess the 
patient’s vital signs.  Monitor lab values.  Allow and assist with gradual return to normal 
activities as symptoms subside.  Perform or teach passive range of motion exercises while 
on bed rest.  Consult dietician about a diet high in calories, low in protein, sodium, 
potassium, and fluids.  Educate on good hygiene, infection prevention  Monitor daily 
weight, I and O.  Assess for and report any sign of peripheral edema or formation of 
ascites.  Explain orthostatic hypotension if patient is on diuretics, and the dizziness when 
quickly changing positions.  Provide emotional support to the patient and family.  If 
dialysis is ordered, fully explain the process to patient and family (Nursing File, 2010).  
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Introduction 
The Group A Streptococcus 
(GAS) bacteria: 
A large group of gram-positive, non-
motile, non-spore-forming cocci. 
•  120 different strains , most common 
bacterial pathogen. Easily treated 
with antibiotics, but widespread. 
• Responsible for more than 700 
million infections around the globe 
each year (Ermet et al., 2015). 
• Untreated, can spread, become 
systemic, organ damage.  
• Major health concern  
• GAS ranks among the top 10 
infectious disease killers worldwide” 
(Walker et al., 2014, p. 286).   
 
The spectrum of diseases caused by GAS 
infections is divided into two categories: 
suppurative and non-suppurative.  
  
Suppurative  
Pharyngitis 
Impetigo  
Pneumonia  
Empyema  
Erysipelas  
Necrotizing fasciitis  
Cellulitis  
Streptococcal bacteremia  
Osteomyelitis  
Otitis media  
Sinusitis  
Meningitis or brain abscess.  
Non-suppurative 
Acute rheumatic fever  
Rheumatic heart disease  
Acute glomerulonephritis 
Scarlet fever 
Endocarditis  
Myocarditis 
Pericarditis 
Phlebitis 
Streptococcal Toxic Shock 
 PANDAS 
Disease burden: 
• Globally, 500,000 deaths annually  
• In U.S. GAS revealed a cost of $500 
million annually” (Steer et al., 2016).   
• 9th leading infectious cause of 
human mortality globally 
• 18.1 million cases of severe disease, 
• 616 million cases of pharyngitis, 
• GAS pharyngitis cost of at least $500 
million annually in US, alone. (Steer 
et al., 2016). 
• Lethality 10-30%  
• Annual death toll 500,000-650,000  
(Terao, 2012). 
  
 
Conclusion 
GAS is an important pathogen 
responsible for 700+ million infections 
worldwide annually.  The global burden 
of invasive strep is I,663,000 new cases, 
163,000 deaths each year (Ermert et al, 
2015).  Quick  identification & treatment 
of  GAS iis paramount to control, arrest 
the disease process, and prevent further 
complications. It is  important to prevent 
spread, as GAS can spread easily 
between humans with close contact; 
droplet spread.  Antibiotic therapy  
treats most GAS infections if caught & 
identified quickly.  The effective 
practitioner needs to be aware of the 
prevalence of GAS infections and assess 
patients, as is appropriate. No age group 
or people group is completely immune to  
GAS.  Further research on a GAS vaccine 
would prove valuable, and once 
developed, the vaccine may help relieve 
some of the worldwide disease burden 
of this powerful pathogen. 
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Reason for Study 
The virulence factors and etiology of this 
bacteria make it a powerful pathogen 
that is capable of creating a large disease 
burden that can affect a family and a 
nation.   Research is revealing genetic 
factors that increase and decrease 
susceptibility to a GAS infection.  As this 
research continues , the quest to develop 
a  GAS vaccine  looks promising, but 
poses many challenges.  These factors 
create several reasons why this powerful 
pathogen is n note-worthy topic, and one 
practitioners need to keep in mind. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
. 
Etiology: 
• Highly communicable 
through person-to-person 
transmission 
• respiratory droplets 
• salivary droplets 
• nasal discharge 
• skin to skin spread known to 
occur with specific strains  
• fingernails and perianal 
region can harbor 
streptococci causing 
impetigo 
• food and waterborne 
outbreaks have been 
documented (Khan, 2016). 
•  Causes disease in healthy 
people of all ages 
• Deficiency in specific type of 
immunity against serotype 
responsible for infection 
(Khan, 2016). 
• Impetigo and pharyngitis 
more likely to occur among 
children living in crowded 
homes or suboptimal 
hygienic conditions (Khan, 
2016). 
• Bacteria can live on dry 
surfaces outside the body 
for 3 days to 6.5 months 
(Whiteman, 2013). 
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Pathophysiology and Significance of 
Pathophysiology 
 
 
 
 
 
Virulence Factors 
• The most common forms, 
respiratory & skin infections,  
• Highly virulent 
• Overcoming host defense   
• Effective/invasive in epithelial cells 
(Khan, 2016).   
• Cell wall complex, chemically 
diverse.   
• Outermost capsule hyaluronic acid 
• Structure resembles host  
• Escapes recognition 
• Extracellular components:  invasins 
and exotoxins,  
• Host cell damage, inflammatory 
response (Khan, 2016). 
• The antigenic components, 
virulence factors:  
• Capsular polysaccharide (C-
substance)  (Khan, 2016). 
• Peptidoglycan, lipoteichoic acid 
(LTA) (Khan, 2016). 
• R and T proteins,  
• Various surface proteins I,M protein 
(Khan, 2016). 
• Cell streptokinase (Khan, 2016) 
• C5A peptidase 
• Bacterial Adhesion Factors (Khan, 
2016). 
• Streptolysin S-damages (Khan, 
2016) 
• Streptolysin O (Khan, 2106) 
• Streptococcal pyrogenic exotoxins 
(SPEs) A,  
• Liquefaction of pus, generates 
substrate for growth (Khan, 2016). 
• inhibition of complement system 
(Stevens & Bryant, 2015). 
• Opacity Factors (Khan, 2016). 
 
S pyogenes colonization, usually in upper respiratory tract, and is 
highly virulent as it overcomes the host defense system.   
Cell wall complex and chemically divers. 
Antigenic components of cell are the virulence factors. 
Extracellular components responsible for disease process 
include invasins and exotoxins. 
Hyaluronic acid outermost capsule escapes recognition by 
host. 
Bacterium escapes phagocytosis by neutrophils or 
macrophages, allowing colonization. 
Epithelial cell invasion 
Complement system activated 
Classical pathway initiated by biding of antibodies to microbial 
surface 
Lectin pathway activated by binding one or more lectins to specific 
carbohydrate structures 
Alternative pathway triggered by ‘tickover’ mechanism followed by 
amplification through positive feedback loop 
All three pathways converge at the level of C3 deposition 
Formation of C3 convertases generates chemoattractant 
anaphylatoxins and further amplifies deposition of C3 fragments on 
microbes, which opsonizes the microbial target for efficient 
phagocytosis.  
Gram-positive bacteria such as GAS are resistant to MAC-mediated 
lysis, but are eliminated by phagocytes following opsonization with 
C3b and iC3b.  
The complement cascade is tightly regulated by surface bound and 
soluble inhibitors (or regulators); C4b-binding protein (C4BP) and 
Factor H (FH) are two examples of the latter which serve to prevent 
damage to host tissues (Ermert et al., 2015). 
“GAS has evolved several virulence factors, which allow the pathogen 
to colonize its human host, escape the immune system and 
successfully establish infection” (Ermert et al.  2015, p. 2) 
Fibrinogen binding to GAS reduces opsonization. 
IgG Fc binding to GAS may prevent recognition by phagocyte Fc 
receptors. 
M protein family members share high sequence identity.  Certain M 
or M-like proteins mediate GAS binding to human C4BP and FH 
through Protein H, which is a member of M protein family.   
Inhibition of complement activation through surface bound human 
FH and C4BP enables GAS infections to evade opsonization. (Ermert 
et al., 2015) 
  
